Novel Coronavirus, COVID-19 Data

This document was last modified: Aug 14, 2020 @ 3:31 pm

 

LINK TO COVID-19 Testing INFORMATION PAGE

Link to COVID-19 Updated Information Page

Will County Infographic HERE

TAKE THE COMMUNITY COVID-19 ANONYMOUS 1 Minute SURVEY

Link to Survey: https://www.surveymonkey.com/r/CWLP7TZ

“WILL COUNTY RESIDENTS, Join your community in protecting each other against COVID-19, a virus that has caused significant global burdens. Take this ANONYMOUS 1 minute survey and let us know what you are doing to prevent Coronavirus from effecting you and your loved ones.”

You can also visit WCHD on Social Media:

https://www.facebook.com/WilCountyHealthDepartment/

https://twitter.com/WillCoHealth

 

Geographical Information System Map: Coronavirus, Local Cases

 

COVID MAP by zip 8.14.20

 

 

 

 

 

*IDPH has defined recovery as those that have not passed away after 42 days of confirmed COVID-19 positive test

 

 

 

 

 

*This graphic is updated in accordance with IDPH, Visit: https://www.dph.illinois.gov/covid19/long-term-care-facility-outbreaks-covid-19

 

 

 

 

 

 

IDPH COVID UPDATE PRESENTATION BELOW: 

To BECOME A CONTACT TRACER, CLICK HERE: https://redcap.dph.illinois.gov/surveys/?s=KWKJL93TM7

Link to Illinois Department of Public Health COVID-19 statistics Page Here: http://www.dph.illinois.gov/covid19/covid19-statistics

 

 

 

 

For Data on Illinois Regional Hospital Resource Utilization, visit: http://dph.illinois.gov/covid19/hospitalization-utilization

RESTORE ILLINOIS PLAN:

Restore Illinois Plan

Restore Illinois Guidelines

Social Determinants of Health and Vulnerable Populations: 

 

 

Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness — United States

Among 3,142 counties, the median estimated (modeled) county prevalence of any underlying medical condition was 47.2% (range = 22.0%–66.2%); obesity, 35.4% (range = 15.2%–49.9%); diabetes, 12.8% (range = 6.1%–25.6%); Chronic Obstructive Pulmonary Disorder, 8.9% (range = 3.5%–19.9%); heart disease, 8.6% (range = 3.5%–15.1%); and Chronic Kidney Disease, 3.4% (range = 1.8%–6.2%)

Counties with the highest prevalence’s of any condition were concentrated in Southeastern states, particularly in Alabama, Arkansas, Kentucky, Louisiana, Mississippi, Tennessee, and West Virginia, as well as some counties in Oklahoma, South Dakota, Texas, and northern Michigan, among others.

Read the Full Article Here: 

https://www.cdc.gov/mmwr/volumes/69/wr/mm6929a1.htm?s_cid=mm6929a1_w

 

 

For more information on COVID-19 stability on surfaces visit: a study conducted by NIH provided information on COVID-19 and stability on surfaces, see here: https://www.nih.gov/news-events/news-releases/new-coronavirus-stable-hours-surfaces

High COVID-19 Attack Rate Among Attendees at Church- Read Full Study Here

 

Factors Associated with Deaths of Critically ill COVID-19 Patients of 65 US Hospital ICU’s

RISK OF INTUBATION AMONG HOSPITAL COVID-19 PATIENTS, Read the Full Article

 

For more information, read the FULL PUBLISHED ARTICLE HERE: jamainternal_gupta_2020_oi_200056 (1)

Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China

“Most patients (125patients[74.4%]) had 1 or more comorbidities. The following distribution of chronic comorbidities among these patients: Hypertension was the most common comorbidity (84patients[50.0%]), followed by diabetes (42patients[25.0%]), and ischemic heart disease (31patients[18.5%]” JAMA

Read Here: Characteristics of mortality COVID CHINA

Comorbidity contributed to nearly 25% of all Coronavirus hospitalizations in China:

a comorbidity analysis of coronavirus in China, read more here: comorbidity of COVID-19 in China

Presymptomatic Transmission of COVID-19

“The evidence of presymptomatic transmission in Singapore, in combination with evidence from other studies (9,10) supports the likelihood that viral shedding can occur in the absence of symptoms and before symptom onset.”

To read more from the CDC on presymtomatic Transmission of COVID-19, Click Here: CDC MMWR Presymptomatic Transmission of COVID-19

A study released related to COVID-19 and transmission in humid environments, Read more here: Case Study COVID-19 and Humidity

“Previous studies have demonstrated that the transmission rate of a virus is significantly weakened in an environment with high temperature and humidity. However, judging from the results of this study, the transmissibility of SARS-CoV-2 showed no signs of weakening in warm and humid conditions. We noticed a clustered case occurring in a public bath center with high temperature and humidity.”

Coronavirus in Italy, Infographic here: Coronavirus in Italy